Clik here to view.
R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation in U.S....
TOKYO R-Tech Ueno (JASDAQ:4573): Sucampo Pharmaceuticals, Inc. (“Sucampo”) announced that it, its affiliate Sucampo AG, R-Tech Ueno, Ltd., Takeda Pharmaceutical Company Limited (Takeda), and certain...
View ArticleClik here to view.
エリテック、欧州バイオ産業協会より2014年「最も革新的な欧州の中小バイオテク企業賞」を受賞
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、欧州バイオ産業協会（EuropaBio）より2014年の「最も革新的な欧州の中小バイオテク企業賞（Most...
View ArticleClik here to view.
Spain VHIR Selects Macrogen as the Genomics Service Partner
BARCELONA, Spain & SEOUL, South Korea The Vall d’Hebron Research Institute (VHIR, www.vhir.org) in Barcelona, Spain, and the world-leading Genomics services company Macrogen (www.macrogen.com)...
View ArticleClik here to view.
ACM Global Central Laboratory Names New Laboratory Manager at Shanghai Facility
ROCHESTER, N.Y. ACM Global Central Laboratory, a diagnostic central laboratory delivering high-quality testing services that optimize clinical trial outcomes, today announced the appointment of Peng...
View ArticleClik here to view.
AHF India Urges Prime Minister Modi to Restore Drug Price Caps
NEW DELHI AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program, AHF India, today urged Indian Prime Minister Narendra Modi to restore drug...
View ArticleClik here to view.
ERYTECH获得EuropaBio颁发的2014年度欧洲生物技术SME最具创新性奖
法国里昂 (美国商业资讯) — ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 – ERYP)是一家法国生物制药公司，开发用于急性白血病和医治需求未获满足的其他肿瘤适应证的创新性“肿瘤饥饿法”治疗，该公司获得EuropaBio颁发的2014年度欧洲生物技术SME最具创新性奖。...
View ArticleClik here to view.
米国ボストン・ストラテジクス社：制がん剤臨床試験で採取された患者さんの腫瘍組織を駆使したトランスレーショナル研究に関して米国モレキュラー・レスポンス社との...
ボストン （ビジネスワイヤ） — 米国マサチューセッツ州ボストンに本社を置く臨床ステージの総合医薬品研究開発会社...
View ArticleClik here to view.
Focus on Excellence in Endoscopy: PENTAX Medical at UEGW 2014
HAMBURG, Germany PENTAX Medical will be presenting the latest technologies and programmes designed to ensure excellence in endoscopy on Stand 9, Hall Y at UEGW 2014, Vienna, 18th-22nd October....
View ArticleClik here to view.
Clinical Trial at Kyoto Medical Center Proves Efficacy of Curcumin in Knee...
KYOTO, Japan The Orthopedics Division at National Hospital Organization, Kyoto Medical Center, announced that it has confirmed the efficacy of Theracrumin®, absorption enhanced curcumin*1 on knee...
View ArticleClik here to view.
Macrogen Introduces Latest Service Portfolio and Presents Research Outcome at...
SAN DIEGO, Calif. & SEOUL, South Korea The integrated genomic service provider, Macrogen (www.macrogen.com) (KRX 038290) has announced its plans to launch new service portfolio and hold an...
View ArticleClik here to view.
R-Tech Ueno: Announcement of Initiation of the Phase I Clinical Trial for the...
TOKYO R-Tech Ueno (JASDAQ: 4573): We are pleased to announce that as of today, the company has started the phase one clinical trial for the new molecular entity RTU-1096, which is a vascular...
View ArticleClik here to view.
Personalis and the Garvan Institute Announce Commercial Partnership for Whole...
MENLO PARK, Calif. & SYDNEY Personalis, Inc., a leading genomics-based clinical research and diagnostics global service provider based in the USA, and the Garvan Institute of Medical Research in...
View ArticleClik here to view.
Humacyte Selected to Join U.S. Secretary of Commerce On Trade Mission to Asia
RESEARCH TRIANGLE PARK, N.C. Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea...
View ArticleClik here to view.
Macrogen Selects GenoLogics’ Clarity LIMS to Strengthen X-Genome and Clinical...
SEOUL, South Korea & SAN FRANCISCO The personalized medicine biotechnology company Macrogen (www.macrogen.com) has announced it has licensed Clarity LIMS from GenoLogics Life Sciences Software...
View ArticleClik here to view.
マクロジェンがX-Genomeサービスおよび臨床シーケンシングサービスを強化するためジェノロジックスのClarity LIMSを選定
韓国ソウル & サンフランシスコ （ビジネスワイヤ） — 個別化治療薬バイオテクノロジー企業のマクロジェン（www.macrogen.com）は、オミックス・ラボ専用にデザインされたLIMSの大手プロバイダーであるジェノロジックス・ライフ・サイエンシズ・ソフトウエア（www.genologics.com）より、Clarity...
View ArticleClik here to view.
Macrogen选择GenoLogics的Clarity LIMS来加强X基因组和临床测序服务
韩国首尔和旧金山 (美国商业资讯)–个体化医学生物技术公司Macrogen (www.macrogen.com)宣布，已从GenoLogics Life Sciences Software (www.genologics.com)获得Clarity LIMS的授权，以支持其全基因组测序和临床测序服务，GenoLogics是专为基因组学实验室设计的LIMS的领先提供商。...
View ArticleClik here to view.
NCKU, University of Ottawa Collaboration Leads to Medical Breakthrough in...
TAINAN, Taiwan A medical discovery made by a joint research team between National Cheng Kung University (NCKU) in southern Taiwan, and University of Ottawa in Canada will help clinicians to better...
View ArticleClik here to view.
エリテック、米国で新たな特許が付与されたと発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、アスパラギナーゼの分野で新たな特許が米国で付与されたことを発表します。 特許（WO 2010/052315...
View ArticleClik here to view.
Aortic Valve Stenosis Treatment in Thailand by Phyathai 2 International Hospital
BANGKOK Phyathai 2 International Hospital’s Heart Center uses the latest techniques and technology available to investigate any heart conditions and provide the best treatment for patients of all...
View ArticleClik here to view.
Gynesonics Receives FDA Approval to Commence a Pivotal IDE Clinical Trial for...
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has received...
View Article